Mitesh

Drug alert number: EL(23)A/06 Date issued: 2 March 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Levothyroxine 12.5mcg Tablets (Teva UK Limited) – PL 00289/1971 Batch Number Expiry Date Pack Size First Distributed 214052 10 2023 28 tablets 20 July 2022 Active Pharmaceutical Ingredients: Levothyroxine Sodium [...]

The post MHRA Class 2 Medicines Recall: Levothyroxine 12.5mcg Tablets (Teva UK Limited) appeared first on PSNC Website.

Update 27/4/2023 – The Department of Health and Social Care (DHSC) has provided an update on 11 Serious Shortage Protocols (SSPs) that were due to expire 28 April 2023. The following SSPs have been further extended to 12 May 2023. Please note that unless there are unexpected changes to the supply situation this will be [...]

The post Contractor Notice: 11 SSPs for Pen V and Sandrena further extended appeared first on PSNC Website.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 7 February 2023) has been published and includes articles on: COVID-19 vaccines and medicines: updates for February 2023 Letters and medicine recalls sent to healthcare professionals in January 2023 To see the latest MHRA Drug Safety Updates in full, visit [...]

The post MHRA Drug Safety Update February 2023 appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estradot® 50mcg patches are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP048 Estradot® 50mcg patches expires at 23.59pm on Friday 24 February 2023. After this date, any prescriptions for Estradot® 50mcg patches must be [...]

The post Contractor Notice: Expiry of SSP048 Estradot® 50mcg patches appeared first on PSNC Website.

Class 4 Medicines Defect Information: Lemsip Max Cold and Flu Capsules (Reckitt Benckiser Healthcare (UK) Limited) Drug alert number: EL (23)A/04 Date issued: 22 February 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for:  Lemsip Max Cold and Flu Capsules, PL 00063/0104 Batch number Expiry [...]

The post MHRA Class 4 Medicines Defect Information: Lemsip Max Cold and Flu Capsules (Reckitt Benckiser Healthcare (UK) Limited) appeared first on PSNC Website.